Lynparza is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Astrazeneca Pharmaceuticals Lp. The primary component is Olaparib.
Product ID | 0310-0679_1843c04f-c7f4-44a3-a8be-7b346e015616 |
NDC | 0310-0679 |
Product Type | Human Prescription Drug |
Proprietary Name | Lynparza |
Generic Name | Olaparib |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2017-08-17 |
Marketing Category | NDA / NDA |
Application Number | NDA208558 |
Labeler Name | AstraZeneca Pharmaceuticals LP |
Substance Name | OLAPARIB |
Active Ingredient Strength | 150 mg/1 |
Pharm Classes | Poly(ADP-Ribose) Polymerase Inhibitor [EPC],Poly(ADP-Ribose) Polymerase Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2017-08-17 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA208558 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2017-08-17 |
Marketing Category | NDA |
Application Number | NDA208558 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2017-08-31 |
Marketing Category | NDA |
Application Number | NDA208558 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2017-08-17 |
Ingredient | Strength |
---|---|
OLAPARIB | 150 mg/1 |
SPL SET ID: | 741ff3e3-dc1a-45a6-84e5-2481b27131aa |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0310-0657 | Lynparza | olaparib |
0310-0668 | Lynparza | olaparib |
0310-0679 | Lynparza | olaparib |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
LYNPARZA 86476170 4991136 Live/Registered |
AstraZeneca AB 2014-12-10 |
LYNPARZA 86190624 4903563 Live/Registered |
AstraZeneca AB 2014-02-11 |